During the projected period, it is anticipated that rising dental caries rates would fuel the expansion of the prosthetic full arch dentures market. For instance, a peer-reviewed paper on July 16, 2021 in the journal BMC Oral Health reported that in 2020, the estimated global prevalence of dental caries in primary and permanent teeth was 46.2% and 53.8%, respectively, which was regarded as high.
The market for Prosthetic Full Arch Dentures is anticipated to reach US$ 1,416.5 Million in 2022 and is projected to grow at a CAGR of 6.1% from 2022 to 2030.
Major Players in the Prosthetic Full Arch Dentures Industry:
Nobel Biocare Services AG:
1. Provider of cosmetic and restorative dentistry services for the medical sector. The business provides cutting-edge implant-based dental restorations by delivering dental, dental solutions, dental implants, implant systems, abutments, guided surgery, customised dental prostheses, and digital dentistry. Born in 1981. Switzerland's Zürich is the headquarters.
DIO Corporation:
2. Dental implants are made and sold in South Korea by DIO Corp. It provides surgical instruments as well as implant systems, such as the UF (II) Narrow, UF (II), SM, and ProTem implant systems. Additionally, the business offers dental supplies, stents, toothpaste, sunscreen, and treatments to hydrate the face. Created in 1988. Head office in South Korea. A share purchase deal for a 26.4 percent stake in DIO Implant, a South Korean implant and surgical system company, was inked on Monday with a consortium chaired by Hong Sung-bum, the director of Shanghai Seouleaguer Hospital and the person responsible for the establishment of botulinum toxin producer Hugel in 2001.